The general consensus among experts is that TRS is a condition in which an individual’s symptoms haven’t responded to two or more antipsychotic medicines given at a therapeutic dose for at ...
17d
Everyday Health on MSNFDA Expands Access to Clozapine for Treatment-Resistant SchizophreniaPatients will no longer need to provide blood test results before they can get clozapine prescriptions filled, according to the FDA.
Clozapine, which was approved in 1989, is regarded by many physicians as the most effective available treatment for schizophrenia, and research shows that the drug significantly reduces suicidal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results